Renhe Pharmacy Co.,Ltd (SHE:000650)
China flag China · Delayed Price · Currency is CNY
5.70
-0.02 (-0.35%)
Apr 29, 2026, 3:04 PM CST

Renhe Pharmacy Co.,Ltd Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
7,8917,8227,9749,2828,66612,857
Market Cap Growth
3.45%-1.91%-14.08%7.11%-32.60%50.56%
Enterprise Value
4,5594,4535,3706,6386,73911,290
Last Close Price
5.705.655.616.245.648.36
PE Ratio
21.6819.8916.5516.3615.0919.33
Forward PE
-10.0810.0810.0810.0810.08
PS Ratio
2.142.211.961.841.682.61
PB Ratio
1.111.131.171.401.352.17
P/TBV Ratio
1.371.391.491.851.892.96
P/FCF Ratio
9.9110.0729.3729.668.2646.26
P/OCF Ratio
9.209.1914.3118.586.8216.53
PEG Ratio
-1.051.051.051.051.05
EV/Sales Ratio
1.241.261.321.321.312.29
EV/EBITDA Ratio
5.335.356.826.156.8011.23
EV/EBIT Ratio
6.306.218.007.037.6712.24
EV/FCF Ratio
5.725.7319.7821.216.4340.62
Debt / Equity Ratio
0000.000.000.00
Debt / EBITDA Ratio
0.000.000.000.010.010.01
Debt / FCF Ratio
0.000.000.010.020.010.02
Net Debt / Equity Ratio
-0.56-0.56-0.55-0.53-0.55-0.47
Net Debt / EBITDA Ratio
-4.76-4.65-4.74-3.27-3.55-2.75
Net Debt / FCF Ratio
-5.00-4.98-13.73-11.28-3.36-9.96
Asset Turnover
0.470.470.550.670.710.74
Inventory Turnover
5.924.385.457.056.255.76
Quick Ratio
5.835.446.615.383.453.43
Current Ratio
6.586.487.576.103.934.19
Return on Equity (ROE)
6.65%7.10%8.42%9.63%11.52%13.83%
Return on Assets (ROA)
5.80%5.89%5.62%7.82%7.56%8.69%
Return on Invested Capital (ROIC)
16.62%17.11%15.83%21.93%21.65%23.88%
Return on Capital Employed (ROCE)
10.10%10.30%9.80%14.10%13.60%15.50%
Earnings Yield
4.68%5.03%6.04%6.11%6.63%5.17%
FCF Yield
10.09%9.93%3.40%3.37%12.10%2.16%
Dividend Yield
2.62%-2.68%3.21%3.54%1.20%
Payout Ratio
57.00%53.53%58.09%49.26%24.40%42.59%
Buyback Yield / Dilution
-0.67%-0.65%0.34%0.08%-1.13%-9.85%
Total Shareholder Return
2.03%-0.65%3.01%3.28%2.42%-8.65%
Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.